- Home
- EBS vs AWP Comparison
EBS vs AWP Comparison
Compare EBS & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- AWP
- Stock Information
- Founded
- EBS 1998
- AWP 2007
- Country
- EBS United States
- AWP United States
- Employees
- EBS N/A
- AWP N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- AWP Trusts Except Educational Religious and Charitable
- Sector
- EBS Health Care
- AWP Finance
- Exchange
- EBS Nasdaq
- AWP Nasdaq
- Market Cap
- EBS 423.6M
- AWP 344.1M
- IPO Year
- EBS 2006
- AWP N/A
- Fundamental
- Price
- EBS $9.11
- AWP $3.86
- Analyst Decision
- EBS Strong Buy
- AWP
- Analyst Count
- EBS 2
- AWP 0
- Target Price
- EBS $13.50
- AWP N/A
- AVG Volume (30 Days)
- EBS 969.4K
- AWP 331.5K
- Earning Date
- EBS 10-29-2025
- AWP 01-01-0001
- Dividend Yield
- EBS N/A
- AWP 12.48%
- EPS Growth
- EBS N/A
- AWP N/A
- EPS
- EBS 2.53
- AWP N/A
- Revenue
- EBS $851,600,000.00
- AWP N/A
- Revenue This Year
- EBS N/A
- AWP N/A
- Revenue Next Year
- EBS $19.24
- AWP N/A
- P/E Ratio
- EBS $3.63
- AWP N/A
- Revenue Growth
- EBS N/A
- AWP N/A
- 52 Week Low
- EBS $4.02
- AWP $3.06
- 52 Week High
- EBS $12.73
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- EBS 54.66
- AWP 35.70
- Support Level
- EBS $9.07
- AWP $3.79
- Resistance Level
- EBS $10.10
- AWP $3.99
- Average True Range (ATR)
- EBS 0.49
- AWP 0.05
- MACD
- EBS 0.01
- AWP -0.02
- Stochastic Oscillator
- EBS 53.00
- AWP 23.17
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.